GNI Group (GNI Group) ROCE % : 54.55% (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is GNI Group ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. GNI Group's annualized ROCE % for the quarter that ended in Dec. 2023 was 54.55%.

GNI Group ROCE % Historical Data

The historical data trend for GNI Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GNI Group ROCE % Chart

GNI Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

8.51

11.55

7.63

5.17

32.00

GNI Group Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															-2.63	2.30	60.18	15.13	54.55

GNI Group ROCE % Calculation

GNI Group's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	96.286	/	( ( (251.321 - 25.968)	+	(433.35 - 56.909) )	/ 2 )
	=	96.286	/	( (225.353	+	376.441)	/ 2 )
	=	96.286	/	300.897
	=	32.00 %

GNI Group's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	182.884	/	( ( (327.83 - 33.727)	+	(433.35 - 56.909) )	/ 2 )
	=	182.884	/	( ( 294.103	+	376.441 )	/ 2 )
	=	182.884	/	335.272
	=	54.55 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

GNI Group (OTCPK:GNIIF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

GNI Group ROCE % Related Terms

Thank you for viewing the detailed overview of GNI Group's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

GNI Group (GNI Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GNI Group Ltd (OTCPK:GNIIF) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

2160:Japan 3G6:Germany

Address

Shinjuku Park Tower, 3-7-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-1030

Website

http://www.gnipharma.com

GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.

GNI Group (GNI Group) Headlines

From GuruFocus

Catalyst Biosciences Inc to Acquire F351 Assets from GNI Group Ltd Call Transcript

By GuruFocus Research • 03-01-2024